Truvestments Capital LLC Ocugen, Inc. Transaction History

Truvestments Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.38 - $15.67 $3,066 - $10,969	-700 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$6.36 - $8.51 $1,272 - $1,702	-200 Reduced 22.22%	700 $5,000
Q2 2021 Aug 12, 2021	SELL	$5.52 - $15.68 $4,140 - $11,760	-750 Reduced 45.45%	900 $7,000
Q1 2021 May 18, 2021	BUY	$1.66 - $15.81 $2,739 - $26,086	1,650 New	1,650 $11,000

124

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $167M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Truvestments Capital LLC with notifications on news.